Sarah Jane Tribble, Kaiser Health News and Rachana Pradhan

Author's posts

Novavax’s Effort to Vaccinate the World, From Zero to Not Quite Warp Speed

Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn’t come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver?